Genetic variants of homocysteine/folate metabolism pathway and risk of inflammatory bowel disease: a synopsis and meta-analysis of genetic association studies

References

• Baumgart DC, Carding SR. (2007). Inflammatory bowel disease: cause and immunobiology. Lancet 369:1627–40.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Sargent M, Vos HL, Rosendaal FR. (2007). Mutations in clotting factors and inflammatory bowel disease. Am J Gastroenterol 102:338–43.
   PubMed Web of Science ®Google Scholar
• Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN. (1997). Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 7:3290–5.
   Google Scholar
• Chapman J, Clayton D. (2007). Detecting association using epistatic information. Genet Epidemiol 31:894–909.
   PubMed Web of Science ®Google Scholar
• Chen M, Peyrin-Biroulet L, Xia B, Gueant-Rodriguez RM, Bronowicki JP, Bigard MA, Guèant JL. (2008). Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis in central China. BMC Med Genet 9:78.
   PubMedGoogle Scholar
• Clayton D, McKeigue PM. (2001). Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 358:1356–60.
   PubMed Web of Science ®Google Scholar
• Cochran WG. (1954). The combination of estimates from different experiments. Biometrics 10:101–29.
   Web of Science ®Google Scholar
• Cooper RS. (2003). Gene-environment interactions and the etiology of common complex disease. Ann Intern Med 139:437–40.
   Google Scholar
• Cordell HJ, Clayton DG. (2005). Genetic association studies. Lancet 366:1121–31.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. (1986). Meta-analysis in clinical trials. Control Clin Trials 7:177–88.
   PubMed Web of Science ®Google Scholar
• Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH. (2006). A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461–3.
   PubMed Web of Science ®Google Scholar
• Egger M, Juni P, Bartlett C, Holenstein F, Sterne J. (2003). How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Health Technol Assess 7:1–76.
   Google Scholar
• Fernández-Miranda C, Martínez Prieto M, Casis Herce B, Sánchez Gómez F, Gómez González P, Martínez López J, Sáenz-López Pérez S, Gómez de la Cámara A. (2005). Hyperhomocysteinemia and methylenetetrahydrofolate reductase 677C–>T and 1298A–>C mutations in patients with inflammatory bowel disease. Rev Esp Enferm Dig 97:497–504.
   PubMedGoogle Scholar
• Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–13.
   PubMed Web of Science ®Google Scholar
• Gaustadnes M, Kluijtmans LA, Jensen OK, Rasmussen K, Heil SG, Kraus JP, Blom HJ, Ingerslev J, Rüdiger N. (1998). Detection of a novel deletion in the cystathionine beta-synthase (CBS) gene using an improved genomic DNA based method. FEBS Lett 431:175–9.
   PubMedGoogle Scholar
• Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, Albrecht M, Mayr G, De La Vega FM, Briggs J, Günther S, Prescott NJ, Onnie CM, Häsler R, Sipos B, Fölsch UR, Lengauer T, Platzer M, Mathew CG, Krawczak M, Schreiber S. (2007). A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39:207–11.
   PubMed Web of Science ®Google Scholar
• Harbord RM, Egger M, Sterne JA. (2006). A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25:3443–57.
   PubMed Web of Science ®Google Scholar
• Hedges LV. Pigott DP. (2001). The power of statistical tests in meta-analysis. Psychol Meth 6:203–17.
   PubMed Web of Science ®Google Scholar
• Herrlinger KR, Cummings JR, Barnardo MC, Schwab M, Ahmad T, Jewell DP. (2005). The pharmacogenetics of methotrexate in inflammatory bowel disease. Pharmacogenet Genomics 15:705–11.
   PubMedGoogle Scholar
• Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603.
   PubMed Web of Science ®Google Scholar
• Juni P, Holenstein F, Sterne J, Bartlett C, Egger M. (2002). Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol 31:115–23.
   PubMed Web of Science ®Google Scholar
• Kitsios GD, Zintzaras E. (2009a). Genomic convergence of genome-wide investigations for complex traits. Ann Hum Genet 73:514–19.
   PubMed Web of Science ®Google Scholar
• Kitsios GD, Zintzaras E. (2009b). Genome-wide association studies: hypothesis. “Free or engaged”? Transl Res 154:161–64.
   PubMed Web of Science ®Google Scholar
• Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. (1992). Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327:248–54.
   PubMed Web of Science ®Google Scholar
• Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, Heng HH, Rommens JM, Scherer SW, Rosenblatt DS, Gravel RA. (1998). Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci U S A 95:3059–64.
   PubMed Web of Science ®Google Scholar
• Ma J, Stampfer MJ, Christensen B, Giovannucci E, Hunter DJ, Chen J, Willett WC, Selhub J, Hennekens CH, Gravel R, Rozen R. (1999). A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 8:825–9.
   PubMed Web of Science ®Google Scholar
• Mahmud N, Molloy A, McPartlin J, Corbally R, Whitehead AS, Scott JM, Weir DG. (1999). Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut 45:389–94.
   PubMed Web of Science ®Google Scholar
• Miller JW, Nadeau MR, Smith D, Selhub J. (1994). Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats. Am J Clin Nutr 59:1033–9.
   PubMed Web of Science ®Google Scholar
• Nakano E, Taylor CJ, Chada L, McGaw J, Powers HJ. (2003). Hyperhomocystinemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 37:586–90.
   PubMedGoogle Scholar
• Namour F, Olivier J, Abdelmouttaleb I, Adjalla C, Debard R, Salvat C, Guéant J. (2001). Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalamin and homocysteine concentration in blood. Blood 97:1092–8.
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuñez G, Cho JH. (2001). A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–6.
   PubMed Web of Science ®Google Scholar
• Papa A, De Stefano V, Danese S, Chiusolo P, Persichilli S, Casorelli I, Zappacosta B, Giardina B, Gasbarrini A, Leone G, Gasbarrini G. (2001). Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease. Am J Gastroenterol 96:2677–82.
   PubMedGoogle Scholar
• Peyrin-Biroulet L, Guéant-Rodriguez RM, Chen M, Bronowicki JP, Bigard MA, Guéant JL. (2008). Association of MTRR 66A>G polymorphism with superoxide dismutase and disease activity in patients with Crohn’s disease. Am J Gastroenterol 103:399–406.
   PubMedGoogle Scholar
• Stipanuk MH. (2004). Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr 24:539–77.
   PubMed Web of Science ®Google Scholar
• Stocco G, Martelossi S, Sartor F, Toffoli G, Lionetti P, Barabino A, Fontana M, Decorti G, Bartoli F, Giraldi T, Ventura A. (2006). Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease. Dig Dis Sci 51:474–9.
   PubMedGoogle Scholar
• Törüner M, Erkan O, Soykan I, Bozdayi M, Cetinkaya H, Yurdaydin C, Uzunalimoğlu O, Ozden A. (2004). Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease. Turk J Gastroenterol 15:250–2.
   PubMedGoogle Scholar
• Trikalinos TA, Salanti G, Zintzaras E, Ioannidis JP. (2008). Meta-analysis methods. Adv Genet 60:311–34.
   PubMed Web of Science ®Google Scholar
• Vecchi M, Sacchi E, Saibeni S, Meucci G, Tagliabue L, Duca F, De Franchis R. (2000). Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis. Dig Dis Sci 45:1465–9.
   PubMed Web of Science ®Google Scholar
• Weir B. (1996). Genetic Data Analysis II: Methods for Discrete Population Genetic Data. Sunderland. MA: Sinauer Associates, 1996.
   Google Scholar
• Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. (1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169–72.
   PubMed Web of Science ®Google Scholar
• Wellcome Trust Case Control Consortium. (2007). Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39:1329–37.
   PubMedGoogle Scholar
• Yasa MH, Bolaman Z, Yukselen V, Kadikoylu G, Karaoglul AO, Batun S. (2007). Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients. Hepatogastroenterology 54:1438–42.
   PubMed Web of Science ®Google Scholar
• Yilmaz S, Bayan K, Tüzün Y, Batun S, Altintaş A. (2006). A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey. J Thromb Thrombolysis 22:205–12.
   PubMedGoogle Scholar
• Zdoukopoulos N, Zintzaras E. (2008). Genetic risk factors for placental abruption: a HuGE review and meta-analysis. Epidemiology 19:309–23.
   PubMedGoogle Scholar
• Zintzaras E, Chatzoulis DZ, Karabatsas CH, Stefanidis I. (2005). The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet 50:267–75.
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Giannouli S, Rodopoulou P, Voulgarelis M. (2008). The role of MTHFR gene in multiple myeloma. J Hum Genet 53:499–507.
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Ioannidis JP. (2005). Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 28:123–37.
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Ioannidis JP. (2008). Meta-analysis for ranked discovery datasets: theoretical framework and empirical demonstration for microarrays. Comput Biol Chem 32:38–46.
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Kitsios G, Stefanidis I. (2006b). Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 48:700–10.
   PubMedGoogle Scholar
• Zintzaras E, Koufakis T, Ziakas PD, Rodopoulou P, Giannouli S, Voulgarelis M. (2006a). A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia. Eur J Epidemiol 21:501–10.
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Lau J. (2008a). Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61:634–45.
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Lau J. (2008b). Trends in meta-analysis of genetic association studies. J Hum Genet 53:1–9.
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Uhlig K, Koukoulis GN, Papathanasiou AA, Stefanidis I. (2007). Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis. J Hum Genet 52:881–90.
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Zdoukopoulos N. (2009). A Field Synopsis and Meta-Analysis of Genetic Association Studies in Peripheral Arterial Disease: The CUMAGAS-PAD Database. Am J Epidemiol 170:1–11.
   PubMed Web of Science ®Google Scholar
• Zintzaras E. (2006a). Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet 51:618–24.
   PubMed Web of Science ®Google Scholar
• Zintzaras E. (2007). Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis. Psychiatr Genet 17:69–75.
   PubMed Web of Science ®Google Scholar
• Zintzaras E. (2006b). C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatr Genet 16:105–15.
   PubMedGoogle Scholar
• Zintzaras E. (2006c). Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Clin Genet 69:327–36.
   PubMed Web of Science ®Google Scholar
• Zintzaras E. (2008). Variance estimation of allele-based odds ratio in the absence of Hardy-Weinberg equilibrium. Eur J Epidemiol 23:323–6.
   PubMed Web of Science ®Google Scholar